Dedicator of cytokinesis 8 (DOCK8) deficiency is an innate error of adaptive immunity characterized by recurrent infections with viruses, bacteria and fungi, very high serum IgE concentrations and a progressive deterioration of T-and B cell-mediated immunity. We studied the genetic and immunological features of two sisters (aged 11 and 6 years).
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This article is protected by copyright. All rights reserved. deficiency was initially thought to be the autosomal recessive form of hyper IgE syndrome (HIES) (2, 8, 9, 10) , but it actually fulfills the criteria of severe combined immunodeficiency in most affected patients and only rarely presents with a mild phenotype, such as isolated atopic dermatitis (7) . DOCK8 mutations may be homozygous or compound heterozygous and typically result in a loss of function of DOCK8. The human DOCK8 gene consists of 48 exons and is spread over 250 kb on chromosome 9p24.3 (1) . DOCK8 is one of the 11 members of DOCK180 family of atypical guanine nucleotide-exchange factors, which function as activators of small G proteins and are involved in regulating the actin cytoskeleton (11) (12) (13) .
Immunological studies in patients with DOCK8 deficiency have revealed T-cell depletion, impaired T-cell expansion in vitro, and secondary antibody responses to specific antigens (4, (14) (15) (16) . Levels of B-cell proliferation and immunoglobulin production upon stimulation with Toll-like receptor (TLR)) 9 were considerably lower in DOCK8-deficient patients than in controls (16) . DOCK8 may function as an adaptor linking TLR-MyD88 signaling pathways essential for TLR-9-driven B-cell activation and DOCK8-deficient patient have fewer CD27-positive memory B cells, potentially accounting for their low IgM level (17) . DOCK8 plays a key role in CD8 T-cell survival and function in both humans and mice (14, 15) . Impaired CD4 + IL-17 + T cell-mediated immunity has also been reported, potentially accounting for the high level of susceptibility of affected patients to chronic mucocutaneous candidiasis (18) . The identification of DOCK8 mutations is challenging, because large deletions may overlap and the data obtained with Sanger sequencing technology may be misleading. We report here two patients who presented with a DOCK8 deficiency phenotype caused by previously unknown large deletions of DOCK8.
This article is protected by copyright. All rights reserved. gene was analyzed. Patient P2, the sister of P1, was referred to us at the age of four years, with suspected HIES. She underwent routine vaccination with no complications. She had had atopic dermatitis since the age of 2.5 years, and had a high serum IgE level, and moderately high blood eosinophil counts. Recurrent respiratory tract infections, including pneumonia, began at the age of 10 months. Serum IgM level was low, IgA level was high and P2 had Tcell lymphopenia ( Table 1 ). Her NIH score was 15, arguing against AD-HIES, and an analysis of the STAT3 gene revealed a wild-type sequence with no mutations. At the age of five years, P2 underwent successful hematopoietic stem cell transplantation, with matched unrelated donor cells, at another hospital.
Immunological assays
Serum immunoglobulin isotypes M, G, A, and E were determined in routine laboratory assays. Lymphocyte subsets were analyzed with a Coulter 500 flow cytometer. Enzyme-linked immunosorbent assays were used to quantify anticapsular IgG antibodies against pneumococcal polysaccharides.
DNA sequencing
Genomic DNA (gDNA) was isolated from peripheral blood mononuclear cells 
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This article is protected by copyright. All rights reserved. primer sequences are available on request. Mutational analysis was performed with the BigDye Terminator Cycle sequencing kit, and an ABI 3130 analyzer (AppliedBiosystems, Foster City, CA). The numbering of DNA and RNA mutations was based on the cDNA sequence (Ensemble: ENST00000453981), with the A of the translation initiation codon counted as the first nucleotide (19) .
MLPA
MLPA (multiplex ligation-dependent probe amplification) analysis was carried out according to the kit manufacturer's instructions (MRC-Holland, Amsterdam, The Netherlands). Briefly, 300 ng DNA was denatured and hybridized overnight at 60°C with the SALSA probe mix P385-A1 DOCK8 and P386-A1DOCK8-STAT3. Samples were then treated with DNA ligase for 15 min at 54°C. The reaction was stopped by incubation at 98°C for 5 min. PCR amplification was carried out with specific fluorescent labeled PCR primers.
Amplification products were subjected to electrophoresis on an ABI PRISM 3100 Genetic Analyzer. Fluorescence intensity was measured after inter-sample and intra-sample normalization.
Western blotting
Protein extracts of PBMCs were subjected to denaturing polyacrylamide gel electrophoresis and the bands obtained were transferred to PVDF membranes (Millipore Corp, Billericay, MA). For detection, the blot was incubated with polyclonal rabbit anti-DOCK8 or anti-actin antibodies (Sigma-Aldrich), and then with horse-radish peroxidase-conjugated anti-rabbit IgG (GE Healthcare, Buckinghamshire, UK). DOCK8 and actin were visualized by chemiluminescence (Termo Scientific, Rockford, IL).
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Results

Analysis of the DOCK8 gDNA with PCR amplicons
PCR amplification of exons and flanking intronic fragments of the DOCK8 gDNA gave normal bands for exons 1-8 and 14-48 ( Fig. 1a ). We sequenced the exon 8 and exon 14 fragments from P1 and found that we had actually amplified fragments from tubulin-tyrosine ligase-like protein 7 (TTLL7) rather than the DOCK8-specific exon 8 sequences observed in controls ( Supplementary Fig. 1 ). Amplification of exon 14 fragments from the patients' DNA actually led to amplification of part of the PR domain-containing protein 11 (PRDM11) gene, rather than the DOCK8-specific exon 14 sequences obtained with the controls ( Supplementary   Fig. 1 ). Furthermore, we obtained single bands on the amplification of exon 12 from both patients. The sequencing of these bands showed them to be p21 protein (CDC42/Rac)activated kinase 6 (PAK6)-specific sequences in the patients and DOCK8-specific sequences in the controls ( Supplementary Fig. 1) . These experiments suggested that the primers used to amplify exons 8, 12, and 14 were able to bind to the sequences of genes other than DOCK8.
Amplification of gDNA from the mother gave normal bands for exons 8 to 14 (Fig. 1b ) and for all the other exons (1-7 and 15-48) (not shown). Similar findings were obtained with the father: all of the exons from 1 to 48 could be amplified (Fig. 1c ). These data suggest that both parents have biallelic or monoallelic wild-type DOCK8 sequences.
Analysis of DOCK8 cDNA with PCR amplicons
We then designed primers for the amplification of cDNA from the patients and the mother (the father was not available for cDNA isolation). We checked the quality of cDNA samples, by first amplifying the GAPDH cDNA as a control ( Fig. 1b and 1c ). Equivalent amplicons were obtained with samples from patients or controls. However, by contrast, no band was
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obtained by amplification of the whole cDNA isolated from the patients (Fig.1c ). We performed PCR amplifications on samples from the patients and the mother, with primers amplifying the cDNA sequences of exons 1-15 and 3-26. We detected a deletion of exons 1 and15 in the patients, but not in the mother (Fig. 1c) . Further experiments with primers designed to amplify exons 3 and 26 clearly indicated the presence of the deletion in both patients, but not in the mother (Fig. 1c) . Sequencing of the amplified exons 3-26 indicated that both patients carried homozygous deletions of exons 8-18 (Fig. 2) . However, the sequencing of the sample from the mother presented us with a further challenge, because the electropherograms showed the sequence present to be wild-type (Fig. 2) .
Identification of DOCK8 mutation sites by MLPA MLPA was performed for both patients and clearly showed that patient P1 had a compound heterozygous deletion mutation affecting exons 1-14 and exons 8-18 (Fig. 3a) . The mother proved to be heterozygous for the deletion of exons 1-14, whereas the father was heterozygous for the deletion of exons 8-18 ( Fig. 3b-d) . These data suggest that the MLPA probe set used here is potentially valuable for the identification of large deletions of DOCK8 and should used as a complement to Sanger sequencing analysis.
Immunoblotting Figure 4 shows immunoblots for DOCK8 protein in the blood cells of the two patients and a healthy control. Lysates were obtained from freshly isolated PBMCs. Consistent with the clinical, immunological and genetic data, we were unable to detect DOCK8 protein on
This article is protected by copyright. All rights reserved. western blots of the patients' PBMC extracts, whereas this protein was clearly detected on control blots (Fig. 4 ).
Discussion
The diagnosis of DOCK8 deficiency is challenging in clinical, immunological and genetic terms. In particular, the differential diagnosis of DOCK8 deficiency and AD-HIES caused by STAT3 mutation on the basis of clinical signs is difficult because the signs of these two diseases overlap ( Table 2 ). Most of the typical clinical findings of AD-HIES are due to connective tissue involvement occurring in children of school age (Table 2) . Thus, these signs and other overlapping signs are not useful for clinical diagnosis. The suspicion of DOCK8 deficiency is increased by the presence of allergy, including life-threatening food allergy in some cases, recurrent viral infections, T-cell lymphopenia and dysgammaglobulinemia ( Table   2 ). The higher rates of malignancy and mortality in patients with DOCK8 deficiency than in patients with AD-HIES requires close attention and the careful follow-up of patients from early childhood.
The identification of deletions in large genes, such as DOCK8, is important for the definitive diagnosis of the disease. The precise diagnosis of DOCK8 deficiency caused by point mutations or small deletions can be made by Sanger sequencing. MLPA has been introduced into DNA diagnostics for the detection of copy number variations due to deletions and duplications in several diseases (20) (21) (22) . One of the objectives of this study was to confirm the clinical and immunological diagnosis of DOCK8 deficiency, by PCR amplification and Sanger sequencing. However, these traditional techniques failed to detect the DOCK8 deletion, probably due to the overlap between the deletions identified in the two heterozygous parents. We therefore decided to use MLPA, a rapid and reliable assay for
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This article is protected by copyright. All rights reserved. yielded similar results. (Fig. 3b and 3c ) The heterozygous deletion of exons 8-18 in the father (3b) and of exons 1-14 in the mother (3c) was demonstrated by MLPA. (Fig. 3d ) Schematic representation of the heterozygosity of the exons 1-14 deletion in the mother and the exons 8-18 deletion in the father, and
Figure legends
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compound heterozygosity of the two new large deletions of DOCK8 found in patients P1 and P2. 
